Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Location status: Recruiting
NCT Number: NCT07278518
This study aims to develop and pilot test a patient decision aid (PtDA) for emergency department (ED)-initiated buprenorphine treatment for opioid use disorder (OUD). The PtDA will be evaluated for acceptability, impact on patient knowledge, decisional conflict, and buprenorphine uptake compared to treatment as usual (TAU).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Charleston, South Carolina, 29425, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This will include information structured for patients about buprenorphine as a treatment options in the emergency department.
Time frame: Day 1
Time frame: pre and post intervention on day 1, and at 7 days
This is a multiple choice knowledge quiz
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1, 7
Contact information is provided by the study sponsor or research team.
Medical University of South Carolina
Other
CTN-0156: Pilot Development and Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06961058
Chemically-Induced Disorders, Disease Attributes
El Centro, California, United States
View Trial DetailsNCT07024498
Chemically-Induced Disorders, Disease Attributes
El Centro, California, United States
View Trial DetailsNCT07129902
Chemically-Induced Disorders, Disease Attributes
Burlington, Vermont, United States
View Trial DetailsNCT06593093
Chemically-Induced Disorders, Disease Attributes
Birmingham, Alabama, United States
View Trial Details